The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, alleging the corporations withheld safety concerns that the medication presented to pediatric cognitive development.
The lawsuit arrives a month after Donald Trump advocated an unproven link between consuming Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in offspring.
The attorney general is filing suit against the pharmaceutical giant, which previously sold the medication, the only pain reliever recommended for expectant mothers, and the current manufacturer, which presently makes it.
In a official comment, he said they "betrayed America by gaining financially from suffering and marketing drugs ignoring the potential hazards."
Kenvue asserts there is insufficient reliable data connecting acetaminophen to autism.
"These corporations deceived for years, knowingly endangering numerous people to line their pockets," the attorney general, from the Republican party, said.
The company stated officially that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the possible consequences that could have on the health of women and children in America."
On its website, Kenvue also stated it had "continuously evaluated the relevant science and there is insufficient valid information that shows a verified association between consuming acetaminophen and autism spectrum disorder."
Groups speaking for doctors and medical practitioners concur.
The American College of Obstetricians and Gynecologists has said acetaminophen - the primary component in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can present major wellness concerns if left untreated.
"In more than two decades of investigation on the use of paracetamol in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any period of pregnancy results in neurological conditions in offspring," the organization stated.
The court filing mentions recent announcements from the Trump administration in claiming the medication is reportedly hazardous.
Recently, the former president raised alarms from health experts when he told pregnant women to "struggle intensely" not to take acetaminophen when unwell.
The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the use of acetaminophen, while also stating that "a causal relationship" between the medication and autism spectrum disorder in minors has remains unverified.
The Health Department head RFK Jr, who supervises the Food and Drug Administration, had pledged in April to initiate "extensive scientific investigation" that would establish the source of autism in a short period.
But specialists warned that identifying a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a complicated interplay of inherited and external influences - would not be simple.
Autism spectrum disorder is a type of permanent neurological difference and disability that impacts how individuals experience and engage with the world, and is identified using medical professional evaluations.
In his legal document, Paxton - who supports Trump who is running for federal office - claims the manufacturer and J&J "intentionally overlooked and sought to suppress the science" around paracetamol and autism spectrum disorder.
This legal action aims to force the firms "destroy any promotional materials" that states acetaminophen is reliable for women during pregnancy.
The Texas lawsuit mirrors the complaints of a assembly of guardians of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in recently.
Judicial authorities rejected the case, stating studies from the family's specialists was not conclusive.
